Envista Holdings Corp
NVSTNYSE
$26.74
↓ -0.9%Jul 17 close · end-of-day
Price
1Y↑ +35.6%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$4.4B
Enterprise Value
$4.8B
P/E
65.2
P/S
1.6
P/B
1.4
EV/EBITDA
13.5
PEG
—
FCF Yield
5.0%
Dividend Yield
—
Revenue (TTM)
$2.8B
Net Income (TTM)
$67.7M
Free Cash Flow (TTM)
$220.2M
Gross Margin
54.9%
Operating Margin
8.5%
Net Margin
2.4%
ROE
2.2%
ROIC
3.5%
Debt / Equity
0.5
Net Cash
-$356.3M
Return 1Y
+35.4%
Company profile
Envista Holdings Corporation engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables.
- CEO
- Amir A. Aghdaei
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 12,700
- Headquarters
- California
- Website
- envistaco.com
Management & directors
- Keel Paul AChief Executive Officer
- Acurio VeronicaPresident, Orthodontics
- Befidi RobertPresident, Diagnostics
- Hammes Eric D.Chief Financial Officer
- Kaabi Faez CChief Accounting Officer
- Nance Mark EGeneral Counsel
- Nilsson StefanPresident, Nobel Biocare
- Reis MischaSVP, Strategy & Bus. Dev.
Roles derived from SEC Form 4 filings.
Earnings
NVST Q1 2026 Earnings
Period ends 2026-04-03
MetricActualYoY
Revenue$705.5M↑ +14.4%
Diluted EPS$0.23↑ +130.0%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $1.9B | $2.5B | $2.6B | $2.6B | $2.5B | $2.7B |
| Gross profit | $1.1B | $1.4B | $1.5B | $1.4B | $1.4B | $1.5B |
| Operating income | $43.5M | $306.2M | $319.2M | $31.5M | -$1.0B | $216.1M |
| Net income | $33.3M | $340.5M | $243.1M | -$100.2M | -$1.1B | $47.0M |
| Diluted EPS | $0.20 | $1.92 | $1.37 | -$0.60 | -$6.50 | $0.28 |
| Operating cash flow | $283.9M | $361.6M | $182.7M | $275.7M | $336.5M | $275.7M |
| Free cash flow | $236.2M | $306.9M | $107.0M | $217.5M | $302.7M | $230.4M |
| Gross margin | 54.7% | 56.9% | 57.4% | 56.1% | 54.7% | 54.7% |
| Operating margin | 2.3% | 12.2% | 12.4% | 1.2% | -41.4% | 7.9% |
| Net margin | 1.7% | 13.6% | 9.5% | -3.9% | -44.6% | 1.7% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $633.1M | $601.0M | $652.9M | $616.9M | $682.1M | $669.9M | $750.6M | $705.5M |
| Gross profit | $326.6M | $317.3M | $372.5M | $336.0M | $369.9M | $370.2M | $410.6M | $390.1M |
| Operating income | -$1.2B | $20.9M | $46.1M | $39.0M | $46.3M | $57.5M | $73.3M | $62.5M |
| Net income | -$1.2B | $8.2M | $1.2M | $18.0M | $26.4M | -$30.3M | $32.9M | $38.7M |
| Diluted EPS | -$6.69 | $0.05 | $0.00 | $0.10 | $0.16 | -$0.18 | $0.20 | $0.23 |
| Operating cash flow | $93.1M | $70.7M | $132.4M | $300,000.00 | $88.7M | $78.7M | $108.0M | -$3.3M |
| Free cash flow | $86.3M | $63.3M | $123.8M | -$5.6M | $76.4M | $67.9M | $91.7M | -$15.8M |
| Gross margin | 51.6% | 52.8% | 57.1% | 54.5% | 54.2% | 55.3% | 54.7% | 55.3% |
| Operating margin | -182.2% | 3.5% | 7.1% | 6.3% | 6.8% | 8.6% | 9.8% | 8.9% |
| Net margin | -181.9% | 1.4% | 0.2% | 2.9% | 3.9% | -4.5% | 4.4% | 5.5% |
Company news
Jul 14, 2026
Jul 10, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-05-25 | Keel Paul A· Chief Executive Officer | Tax withholding | 12,811 | $23.43 | $300,161.73 | filing |
| 2026-05-19 | Carruthers Wendy | Award | 9,330 | $0.00 | $0.00 | filing |
| 2026-05-19 | TSINGOS CHRISTINE A | Award | 9,330 | $0.00 | $0.00 | filing |
| 2026-05-19 | Jain Vivek | Award | 9,330 | $0.00 | $0.00 | filing |
| 2026-05-19 | GALLAHUE KIERAN | Award | 9,330 | $0.00 | $0.00 | filing |
| 2026-05-19 | Pierce James Andrew | Award | 9,330 | $0.00 | $0.00 | filing |
| 2026-05-19 | Raskas Daniel | Award | 9,330 | $0.00 | $0.00 | filing |
| 2026-05-19 | Huennekens R Scott | Award | 12,585 | $0.00 | $0.00 | filing |
| 2026-02-25 | Keel Paul A· Chief Executive Officer | Tax withholding | 11,840 | $29.59 | $350,345.60 | filing |
| 2026-02-25 | Kaabi Faez C· Chief Accounting Officer | Tax withholding | 4,964 | $29.59 | $146,884.76 | filing |
| 2026-02-25 | Nance Mark E· General Counsel | Tax withholding | 3,368 | $29.59 | $99,659.12 | filing |
| 2026-02-25 | Reis Mischa· SVP, Strategy & Bus. Dev. | Tax withholding | 2,976 | $29.59 | $88,059.84 | filing |
| 2026-02-25 | Befidi Robert· President, Diagnostics | Tax withholding | 2,177 | $29.59 | $64,417.43 | filing |
| 2026-02-25 | Hammes Eric D.· Chief Financial Officer | Tax withholding | 2,045 | $29.59 | $60,511.55 | filing |
| 2026-02-25 | Acurio Veronica· President, Orthodontics | Tax withholding | 1,412 | $29.59 | $41,781.08 | filing |
| 2026-02-25 | Nilsson Stefan· President, Nobel Biocare | Tax withholding | 182 | $29.59 | $5,385.38 | filing |
| 2026-02-25 | Reis Mischa· SVP, Strategy & Bus. Dev. | Award | 5,915 | $0.00 | $0.00 | filing |
| 2026-02-25 | Nance Mark E· General Counsel | Award | 12,675 | $0.00 | $0.00 | filing |
| 2026-02-25 | Hammes Eric D.· Chief Financial Officer | Award | 16,055 | $0.00 | $0.00 | filing |
| 2026-02-25 | Kaabi Faez C· Chief Accounting Officer | Award | 13,520 | $0.00 | $0.00 | filing |
| 2026-02-25 | Acurio Veronica· President, Orthodontics | Award | 7,605 | $0.00 | $0.00 | filing |
| 2026-02-25 | Keel Paul A· Chief Executive Officer | Award | 48,670 | $0.00 | $0.00 | filing |
| 2026-02-25 | Nilsson Stefan· President, Nobel Biocare | Award | 7,605 | $0.00 | $0.00 | filing |
| 2026-02-25 | Befidi Robert· President, Diagnostics | Award | 7,605 | $0.00 | $0.00 | filing |
| 2026-02-10 | Reis Mischa· SVP, Strategy & Bus. Dev. | Sale | 5,634 | $30.00 | $169,020.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.